慢性肾脏病认知障碍模式的新评估方法
在CKD-REIN队列3003例3-4期CKD患者中随访5年,采用MMSE评估认知模式;基线eGFR较低与定向力、注意力与计算力、语言及运用力领域早期损害相关,但基线eGFR与MMSE各领域评分随时间变化无显著关联。
要点
- 基线eGFR每降低10 mL/min/1.73 m2,定向力评分降低0.53分、注意力与计算力降低1.04分、语言降低0.78分、运用力降低0.94分。
- 基线eGFR与MMSE各领域评分随时间变化无显著关联。
- CKD患者认知筛查宜优先评估执行功能、注意力与语言,而非记忆测试。
核心结论
- CKD患者较低eGFR与运用力、语言及注意力领域早期损害相关,出现在明显认知下降之前。
- CKD患者NCD早期检测应在临床认知下降前进行,优先采用评估执行功能、注意力与语言的测试而非记忆测试。
研究设计与样本
- 基于CKD-REIN队列,纳入3003例CKD 3-4期患者,随访5年。
- 采用MMSE评估认知模式,将MMSE评分归一化至0-100量表。
- 采用线性混合模型评估基线eGFR(CKD-EPI肌酐公式)与各MMSE领域评分变化之间的关联。
主要发现
- 患者年龄67±13岁,男性65%,平均eGFR 33±12 mL/min/1.73 m2,基线平均MMSE评分26.9/30±2.9。
- 校正年龄、性别、教育水平、抑郁(既往或现患)、心血管危险因素及脑血管病后,基线eGFR每降低10 mL/min/1.73 m2与定向力评分降低0.53分相关[P<.001;95%CI(-0.98,-0.08)]。
- 基线eGFR每降低10 mL/min/1.73 m2与注意力与计算力评分降低1.04分相关[P=.03;95%CI(-1.96,-0.13)]。
- 基线eGFR每降低10 mL/min/1.73 m2与语言评分降低0.78分相关[P=.003;95%CI(-1.30,-0.27)]。
- 基线eGFR每降低10 mL/min/1.73 m2与运用力评分降低0.94分相关[P=.02;95%CI(-1.75,-0.13)];基线eGFR与MMSE各领域评分随时间变化无显著关联。
临床怎么用
- CKD患者认知筛查宜在临床认知下降前进行,优先采用评估执行功能、注意力与语言的测试而非记忆测试。
- 早期认知筛查可能有助于更好管理认知障碍及其对CKD管理的影响。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) is associated with an elevated risk of neurocognitive disorders (NCDs). It remains unclear whether CKD-related NCDs have a specific cognitive pattern or are earlier-onset phenotypes of the main NCDs (vascular NCDs and Alzheimer's disease). METHODS: We used the Mini Mental State Examination score (MMSE) to assess cognitive patterns in 3003 CKD patients (stage 3-4) followed up over 5 years in the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort. After normalizing MMSE scores to a 0-to-100 scale, the associations between the baseline estimated glomerular filtration rate (eGFR, using the Chronic Kidney Disease Epidemiology Collaboration creatinine formula) and changes in each MMSE domain score were assessed in linear mixed models. RESULTS: Patients (age: 67 ± 13 years old; males: 65%, mean eGFR: 33± 12 mL/min/1.73 m2) had a good baseline cognitive functions: the mean MMSE score was 26.9/30 ± 2.9. After adjustment for age, sex, educational level, depression (past or present), cardiovascular risk factors and cerebrovascular disease, a lower baseline eGFR (per 10 mL/min/1.73 m2) was associated with a 0.53-point decrement [P < .001; 95% confidence interval (CI) (-0.98, -0.08)] for orientation, a 1.04-point decrement [P = .03; 95% CI (-1.96, -0.13)] for attention and calculation, a 0.78-point decrement [P = .003; 95% CI (-1.30, -0.27)] for language, and a 0.94-point decrement [P = .02; 95% CI (-1.75, -0.13)] for praxis. Baseline eGFR was not, however, associated with significant changes over time in MMSE domain scores. CONCLUSION: A lower eGFR in CKD patients was associated with early impairments in certain cognitive domains: praxis, language and attention domains before an obvious cognitive decline. Early detection of NCD in CKD patients must be performed before clinically cognitive decline using preferably tests assessing executive, attentional functions and language, rather than memory tests. This early cognitive screening could lead to a better management of cognitive impairment and their consequences on CKD management.
引用
- Levassort H, Boucquemont J, Alencar de Pinho N, et al. A new approach for cognitive impairment pattern in chronic kidney disease. Nephrol Dial Transplant. 2024. PMID: 37950574. doi:10.1093/ndt/gfad244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。